BackKalVista Pharmaceuticals Overview

KalVista Pharmaceuticals Total Assets

Latest total assets for KALV: $340M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$335.38M
21.52% YoYΔ $59.38M vs prior year quarter

Peer trimmed avg / median

Loading

KalVista Pharmaceuticals Total Assets History

Loading

KalVista Pharmaceuticals vs. peers: Total Assets Comparison

Loading

KalVista Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

KalVista Pharmaceuticals (KALV) FAQ

As of the most recent data (January 2026), KALV shows a total assets of $340M. That compares with $280M in the prior-year period — up 21.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, KALV's total assets is now $340M (was $280M) — a 21.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether KalVista Pharmaceuticals is outperforming or lagging.

Tracking KALV's total assets over time shows whether KalVista Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $340M That compares with $280M in the prior-year period — up 21.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has KalVista Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $340M) with ownership activity and broader fundamentals.

KalVista Pharmaceuticals's total assets is $340M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.